Imunon, a clinical-stage biotech company, announced a conference call on November 12, 2026, to discuss its Q3 financial results and provide updates on its DNA-based immunotherapy IMNN-001. The company is advancing Phase 3 clinical trials of IMNN-001 for newly diagnosed advanced ovarian cancer, aiming to deliver targeted cancer treatment using DNA-mediated therapy. This update is significant as it highlights progress in developing innovative cancer treatments with potential to improve patient outcomes. Investors can join the call via phone or webcast, with a replay available for 90 days.
Imunon’s upcoming Q3 2026 financial results call is noted here alongside Pluang’s health sector market data as of Nov 02, 2026 20:02 WIB. Among 150 priced health-sector US stocks tradable on Pluang, 87 rose and 43 fell today. Notable movers include DNA (Ginkgo Bioworks Holdings Inc) up 2.85% at USD 11.55, MRVI (Maravai LifeSciences Holdings Inc) up 2.82% at USD 8.03, and MMED (MiniMed Group Inc) down 2.95% at USD 17.74, with typical hold times ranging from 9 to 14 days.
Maurizio Mian, known as the pioneer of influencer culture, has launched a new micro-drama series called 'The Experiment.' The show features popular social media personalities living in luxury while exploring whether happiness can be measured and incr...
The global wealth management software market, valued at $6.28 billion in 2025, is projected to reach $18.77 billion by 2033, growing at a 14.7% CAGR. Growth is fueled by rising adoption of AI, automation, and digital advisory tools that enhance workf...
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
